STRATA Skin Sciences (SSKN) Revenue Growth (3y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | -4.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.30% |
| Sep 30, 2025 | -9.71% |
| Jun 30, 2025 | -5.59% |
| Mar 31, 2025 | -1.10% |
| Dec 31, 2024 | 1.87% |
| Sep 30, 2024 | 4.49% |
| Jun 30, 2024 | 4.55% |
| Mar 31, 2024 | 5.04% |
| Dec 31, 2023 | 8.96% |
| Sep 30, 2023 | 16.40% |
| Jun 30, 2023 | 26.97% |
| Mar 31, 2023 | 3.98% |
| Dec 31, 2022 | 6.01% |
| Sep 30, 2022 | 7.96% |
| Jun 30, 2022 | 5.63% |
| Mar 31, 2022 | -2.01% |
| Dec 31, 2021 | 4.23% |
| Sep 30, 2021 | -0.08% |
| Jun 30, 2021 | -0.03% |
| Mar 31, 2021 | -4.73% |
| Dec 31, 2020 | -7.89% |
| Sep 30, 2020 | -9.03% |
| Jun 30, 2020 | -21.85% |
| Mar 31, 2020 | -2.54% |
| Dec 31, 2019 | 5.48% |
| Sep 30, 2019 | -1.25% |
| Jun 30, 2019 | -0.06% |
| Mar 31, 2019 | -0.60% |
| Dec 31, 2018 | -5.50% |
| Sep 30, 2018 | -2.44% |
| Jun 30, 2018 | 129.52% |
| Mar 31, 2018 | 336.53% |
| Dec 31, 2017 | 184.30% |
| Sep 30, 2017 | 224.60% |
| Jun 30, 2017 | 234.82% |
| Mar 31, 2017 | 320.68% |
| Dec 31, 2016 | 278.51% |
| Sep 30, 2016 | 316.23% |
| Jun 30, 2016 | 277.03% |
| Mar 31, 2016 | 275.34% |
| Dec 31, 2015 | 326.88% |
| Sep 30, 2015 | 393.79% |
| Jun 30, 2015 | 100.54% |
| Mar 31, 2015 | 93.10% |